-
1
-
-
77951693545
-
Surgery for colorectal liver metastases
-
Primrose JN (2010) Surgery for colorectal liver metastases. Br J Cancer 102:1313-8.
-
(2010)
Br J Cancer
, vol.102
, pp. 1313-1318
-
-
Primrose, J.N.1
-
2
-
-
70350164862
-
Surgical management of hepatic metastases of colorectal origin
-
Gilson N, Honoré C, Detry O, De Roover A, Coimbra C, et al (2009) Surgical management of hepatic metastases of colorectal origin. Acta Gastroenterol Belg 72:321-6.
-
(2009)
Acta Gastroenterol Belg
, vol.72
, pp. 321-326
-
-
Gilson, N.1
Honoré, C.2
Detry, O.3
De Roover, A.4
Coimbra, C.5
-
3
-
-
84859715398
-
Peri-operative chemotherapy for resectable colorectal liver metastasis: Does timing of systemic therapy matter?
-
Pinto Marques H, Barroso E, de Jong MC, Choti MA, Ribeiro V, et al (2012) Peri-operative chemotherapy for resectable colorectal liver metastasis: does timing of systemic therapy matter? J Surg Oncol 105:511-9.
-
(2012)
J Surg Oncol
, vol.105
, pp. 511-519
-
-
Pinto Marques, H.1
Barroso, E.2
De Jong, M.C.3
Choti, M.A.4
Ribeiro, V.5
-
4
-
-
0036104072
-
Trends in long-term survival following liver resection for hepatic colorectal metastases
-
DOI 10.1097/00000658-200206000-00002
-
Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, et al (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235:759-66. (Pubitemid 34547293)
-
(2002)
Annals of Surgery
, vol.235
, Issue.6
, pp. 759-766
-
-
Choti, M.A.1
Sitzmann, J.V.2
Tiburi, M.F.3
Sumetchotimetha, W.4
Rangsin, R.5
Schulick, R.D.6
Lillemoe, K.D.7
Yeo, C.J.8
Cameron, J.L.9
-
5
-
-
80054742886
-
Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer
-
Xu J, Qin X, Wang J, Zhang S, Zhong Y, et al (2011) Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol 137:1379-96.
-
(2011)
J Cancer Res Clin Oncol
, vol.137
, pp. 1379-1396
-
-
Xu, J.1
Qin, X.2
Wang, J.3
Zhang, S.4
Zhong, Y.5
-
6
-
-
34250803443
-
Hepatectomy for Resectable Colorectal Cancer Metastases-Indicators of Prognosis, Definition of Resectability, Techniques and Outcomes
-
DOI 10.1016/j.soc.2007.04.014, PII S1055320707000427, Metastasectomy and Cytoreductive Surgery
-
Lupinacci R, Penna C, Nordlinger B (2007) Hepatectomy for resectable colorectal cancer metastases-indicators of prognosis, definition of resectability, techniques and outcomes. Surg Oncol Clin N Am 16:493-506. (Pubitemid 46990949)
-
(2007)
Surgical Oncology Clinics of North America
, vol.16
, Issue.3
, pp. 493-506
-
-
Lupinacci, R.1
Penna, C.2
Nordlinger, B.3
-
7
-
-
68949094312
-
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy
-
Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, et al (2009) Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27:3677-83.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3677-3683
-
-
Kopetz, S.1
Chang, G.J.2
Overman, M.J.3
Eng, C.4
Sargent, D.J.5
-
8
-
-
78650631803
-
Evolution of neoadjuvant therapy for extended hepatic metastases-have we reached our (non-resectable) limit?
-
Adam R, Hoti E, Bredt LC (2010) Evolution of neoadjuvant therapy for extended hepatic metastases-have we reached our (non-resectable) limit? J Surg Oncol 102:922-31.
-
(2010)
J Surg Oncol
, vol.102
, pp. 922-931
-
-
Adam, R.1
Hoti, E.2
Bredt, L.C.3
-
9
-
-
77952302964
-
Role of adjuvant therapy after resection of colorectal cancer liver metastases
-
Power DG, Kemeny NE (2010) Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol 28:2300-9.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2300-2309
-
-
Power, D.G.1
Kemeny, N.E.2
-
10
-
-
84866362258
-
Resectable colorectal liver metastases: Optimal sequencing of chemotherapy
-
Chua TC, Morris DL (2012) Resectable colorectal liver metastases: optimal sequencing of chemotherapy. J Gastrointest Cancer 43:496-8.
-
(2012)
J Gastrointest Cancer
, vol.43
, pp. 496-498
-
-
Chua, T.C.1
Morris, D.L.2
-
11
-
-
40749149728
-
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): A randomised controlled trial
-
DOI 10.1016/S0140-6736(08)60455-9, PII S0140673608604559
-
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, et al (2008) Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 371:1007-16. (Pubitemid 351392040)
-
(2008)
The Lancet
, vol.371
, Issue.9617
, pp. 1007-1016
-
-
Nordlinger, B.1
Sorbye, H.2
Glimelius, B.3
Poston, G.J.4
Schlag, P.M.5
Rougier, P.6
Bechstein, W.O.7
Primrose, J.N.8
Walpole, E.T.9
Finch-Jones, M.10
Jaeck, D.11
Mirza, D.12
Parks, R.W.13
Collette, L.14
Praet, M.15
Bethe, U.16
Van Cutsem, E.17
Scheithauer, W.18
Gruenberger, T.19
-
12
-
-
84868143414
-
EORTC liver metastases intergroup randomized Phase III Study 40983: Long-term survival results
-
abstr 3508
-
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, et al (2012) EORTC liver metastases intergroup randomized Phase III Study 40983: long-term survival results. J Clin Oncol 30(suppl):abstr 3508.
-
(2012)
J Clin Oncol
, vol.30
, Issue.SUPPL.
-
-
Nordlinger, B.1
Sorbye, H.2
Glimelius, B.3
Poston, G.J.4
Schlag, P.M.5
-
13
-
-
84857649652
-
Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983)
-
Sorbye H, Mauer M, Gruenberger T, Glimelius B, Poston GJ, et al (2012) Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983). Ann Surg 255:534-9.
-
(2012)
Ann Surg
, vol.255
, pp. 534-539
-
-
Sorbye, H.1
Mauer, M.2
Gruenberger, T.3
Glimelius, B.4
Poston, G.J.5
-
14
-
-
77953035157
-
Pre-operative chemotherapy for colorectal cancer liver metastases:An update of recent clinical trials
-
Nasti G, Ottaiano A, Berretta M, Delrio P, Izzo F, et al (2010) Pre-operative chemotherapy for colorectal cancer liver metastases:an update of recent clinical trials. Cancer Chemother Pharmacol 66:209-18.
-
(2010)
Cancer Chemother Pharmacol
, vol.66
, pp. 209-218
-
-
Nasti, G.1
Ottaiano, A.2
Berretta, M.3
Delrio, P.4
Izzo, F.5
-
15
-
-
67651227762
-
Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases
-
Chiappa A, Bertani E, Makuuchi M, Zbar AP, Contino G, et al (2009) Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases. Hepatogastroenterology 56:829-34.
-
(2009)
Hepatogastroenterology
, vol.56
, pp. 829-834
-
-
Chiappa, A.1
Bertani, E.2
Makuuchi, M.3
Zbar, A.P.4
Contino, G.5
-
16
-
-
44149107591
-
Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases
-
Gruenberger B, Scheithauer W, Punzengruber R, Zielinski C, Tamandl D, et al (2008) Importance of response to neoadjuvant chemotherapy in potentially curable colorectal cancer liver metastases. BMC Cancer 8:120.
-
(2008)
BMC Cancer
, vol.8
, pp. 120
-
-
Gruenberger, B.1
Scheithauer, W.2
Punzengruber, R.3
Zielinski, C.4
Tamandl, D.5
-
17
-
-
42949130734
-
Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer
-
Gruenberger B, Tamandl D, Schueller J, Scheithauer W, Zielinski C, et al (2008) Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol 26:1830-5.
-
(2008)
J Clin Oncol
, vol.26
, pp. 1830-1835
-
-
Gruenberger, B.1
Tamandl, D.2
Schueller, J.3
Scheithauer, W.4
Zielinski, C.5
-
18
-
-
77149163805
-
Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases
-
Chua TC, Saxena A, Liauw W, Kokandi A, Morris DL (2010) Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases. Ann Surg Oncol 17:492-501.
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 492-501
-
-
Chua, T.C.1
Saxena, A.2
Liauw, W.3
Kokandi, A.4
Morris, D.L.5
-
19
-
-
66149155832
-
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: Recommendations from an expert panel
-
Nordlinger B, Van Cutsem E, Gruenberger T, Glimelius B, Poston G, et al (2009) Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. Ann Oncol 20:985-92.
-
(2009)
Ann Oncol
, vol.20
, pp. 985-992
-
-
Nordlinger, B.1
Van Cutsem, E.2
Gruenberger, T.3
Glimelius, B.4
Poston, G.5
-
20
-
-
78349300856
-
Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases?
-
Adam R, Bhangui P, Poston G, Mirza D, Nuzzo G, et al (2010) Is perioperative chemotherapy useful for solitary, metachronous, colorectal liver metastases? Ann Surg 252:774-87.
-
(2010)
Ann Surg
, vol.252
, pp. 774-787
-
-
Adam, R.1
Bhangui, P.2
Poston, G.3
Mirza, D.4
Nuzzo, G.5
-
21
-
-
83555164958
-
Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases?
-
Reddy SK, Tsung A, Marsh JW, Geller DA (2012) Does neoadjuvant chemotherapy reveal disease precluding surgical treatment of initially resectable colorectal cancer liver metastases? J Surg Oncol 105:55-9.
-
(2012)
J Surg Oncol
, vol.105
, pp. 55-59
-
-
Reddy, S.K.1
Tsung, A.2
Marsh, J.W.3
Geller, D.A.4
-
22
-
-
75449088980
-
Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver
-
Cleary JM, Tanabe KT, Lauwers GY, Zhu AX (2009) Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver. Oncologist 14:1095-105.
-
(2009)
Oncologist
, vol.14
, pp. 1095-1105
-
-
Cleary, J.M.1
Tanabe, K.T.2
Lauwers, G.Y.3
Zhu, A.X.4
-
23
-
-
79954614862
-
Systemic chemotherapy and its implications for resection of colorectal liver metastasis
-
Robinson S, Manas DM, Pedley I, Mann D, White SA (2011) Systemic chemotherapy and its implications for resection of colorectal liver metastasis. Surg Oncol 20:57-72.
-
(2011)
Surg Oncol
, vol.20
, pp. 57-72
-
-
Robinson, S.1
Manas, D.M.2
Pedley, I.3
Mann, D.4
White, S.A.5
-
24
-
-
33646457231
-
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
-
DOI 10.1200/JCO.2005.05.3074
-
Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-72. (Pubitemid 46622116)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.13
, pp. 2065-2072
-
-
Vauthey, J.-N.1
Pawlik, T.M.2
Ribero, D.3
Wu, T.-T.4
Zorzi, D.5
Hoff, P.M.6
Xiong, H.Q.7
Eng, C.8
Lauwers, G.Y.9
Mino-Kenudson, M.10
Risio, M.11
Muratore, A.12
Capussotti, L.13
Curley, S.A.14
Abdalla, E.K.15
-
25
-
-
79955618076
-
Complete radiological response of colorectal liver metastases after chemotherapy: What can we expect?
-
Gaujoux S, Goéré D, Dumont F, Souadka A, Dromain C, et al (2011) Complete radiological response of colorectal liver metastases after chemotherapy: what can we expect? Dig Surg 28:114-20.
-
(2011)
Dig Surg
, vol.28
, pp. 114-120
-
-
Gaujoux, S.1
Goéré, D.2
Dumont, F.3
Souadka, A.4
Dromain, C.5
-
26
-
-
68949217661
-
The role of preoperative chemotherapy in patients with resectable colorectal liver metastases
-
Benoist S, Nordlinger B (2009) The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol 16:2385-90.
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 2385-2390
-
-
Benoist, S.1
Nordlinger, B.2
-
27
-
-
79952073020
-
The role of peri-operative chemotherapy for resectable colorectal liver metastasis: What does the evidence support?
-
Pawlik TM, Cosgrove D (2011) The role of peri-operative chemotherapy for resectable colorectal liver metastasis: what does the evidence support? J Gastrointest Surg 15:410-5.
-
(2011)
J Gastrointest Surg
, vol.15
, pp. 410-415
-
-
Pawlik, T.M.1
Cosgrove, D.2
-
28
-
-
77953576166
-
Prognostic scores for colorectal liver metastasis: Clinically important or an academic exercise?
-
Oxford
-
Gomez D, Cameron IC (2010) Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) 12:227-38.
-
(2010)
HPB
, vol.12
, pp. 227-238
-
-
Gomez, D.1
Cameron, I.C.2
|